Skip to content

Chernett Jorey

Reporting owner on Forms 3, 4 and 5, CIK 2042077.

Chernett Jorey reported on 3 issuers in 18 filings, the latest a 13D/A filed 2026-11-19.

Issuers

IssuerRoles in the latest filingFilingsLast filed
STIM · Neuronetics, Inc.CIK 122763610% owner22026-11-13
XGN · EXAGEN INC.CIK 127473710% owner52026-11-13
Starling Oncology, Inc. CIK 179919110% owner32026-11-13

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
STIM · Neuronetics, Inc.Common Stock2026-11-13S sold-2,187,051$1.157,325,577Form 4
XGN · EXAGEN INC.Common Stock2026-11-13S sold-58,068$4.082,529,436Form 4
STIM · Neuronetics, Inc.Common Stock2026-11-12S sold-706,840$1.439,512,628Form 4
XGN · EXAGEN INC.Common Stock2026-11-12S sold-109,436$4.652,587,504Form 4
STIM · Neuronetics, Inc.Common Stock2026-11-11S sold-86,757$1.6110,219,468Form 4
STLN · Starling Oncology, Inc.Call Option (STLN 19FEB27 $4C), derivative2026-11-11P bought+1,391$0.86,391Form 4/A
XGN · EXAGEN INC.Common Stock2026-11-11P bought+71,315$5.232,696,940Form 4
STLN · Starling Oncology, Inc.Call Option (STLN 19FEB27 $4C), derivative, superseded by an amendment2026-11-11P bought+1,391$0.86,391Form 4
XGN · EXAGEN INC.Common Stock2026-11-10P bought+7,085$5.262,625,625Form 4
STLN · Starling Oncology, Inc.Call Option (STLN 21MAY27 $5C), derivative2026-11-10P bought+7,000$0.677,000Form 4
STIM · Neuronetics, Inc.Common Stock2026-11-09S sold-103,959$2.0610,266,225Form 4
STIM · Neuronetics, Inc.Common Stock2026-11-09P bought+40,000$1.9910,306,225Form 4
XGN · EXAGEN INC.Common Stock2026-11-09P bought+8,500$6.352,618,540Form 4
STLN · Starling Oncology, Inc.Common Stock2026-11-09P bought+48,294$3.657,858,091Form 4
STLN · Starling Oncology, Inc.Call Option (STLN 19FEB27 $5C), derivative2026-11-09P bought+7,500$0.53577,500Form 4
STIM · Neuronetics, Inc.Common Stock2026-11-06S sold-250,804$2.3910,370,184Form 4
XGN · EXAGEN INC.Common Stock2026-11-06S sold-11,265$6.142,610,040Form 4
STLN · Starling Oncology, Inc.Common Stock2026-11-06S sold-2,851,061$3.997,809,797Form 4
STLN · Starling Oncology, Inc.Call Option (STLN 20NOV26 $4C), derivative2026-11-06P bought+10,000$0.07510,000Form 4
STLN · Starling Oncology, Inc.Call Option (STLN 19FEB27 $4C), derivative2026-11-06P bought+5,000$0.45,000Form 4
STIM · Neuronetics, Inc.Common Stock2026-10-30P bought+18,000$2.2710,620,988Form 4
XGN · EXAGEN INC.Common Stock2026-10-19P bought+14,000$7.462,618,540Form 4
XGN · EXAGEN INC.Common Stock, holding 2,604,540Form 3

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
13D/A 0000921895-26-003225 SMHI2026-11-19
13G/A 0000921895-26-003192 TRAW2026-11-16
13G/A 0000921895-26-003190 Axonics2026-11-16
13G/A 0000921895-26-003188 FEMY2026-11-16
13D/A 0001193805-26-001478 STIM2026-11-16
13G/A 0001193805-26-001476 XGN2026-11-13
13G/A 0001193805-26-001475 XGN2026-11-13
Form 4 0001193805-26-001472 Neuronetics, Inc.2026-11-13
Form 4 0001193805-26-001471 EXAGEN INC.2026-11-13
Form 4/A 0001193805-26-001470 Starling Oncology, Inc.2026-11-13
Form 4 0001193805-26-001456 EXAGEN INC.2026-11-12
Form 4 0001193805-26-001455 Starling Oncology, Inc.2026-11-12
Form 4 0000921895-26-003021 EXAGEN INC.2026-11-10
Form 4 0000921895-26-003018 Starling Oncology, Inc.2026-11-10
Form 4 0000921895-26-002891 Neuronetics, Inc.2026-11-02
Form 4 0001193805-26-001382 EXAGEN INC.2026-10-20
Form 3 0001193805-26-001378 EXAGEN INC.2026-10-19
13D/A 0001193805-26-001332 CVRX2026-10-02